GlassScriptPhysician profile
Terry V Kelley
NPI 1700836269
$1,978.42
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $147 · 2021: $235 · 2022: $637 · 2023: $230 · 2024: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $590.66 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $282.90 | 2021-2024 | |
| Aspira Women'S Health INC | $134.29 | 2022 | |
| Therapeuticsmd, INC. | $117.02 | 2019-2022 | |
| Pfizer INC. | $86.38 | 2019-2022 | |
| Coopersurgical, INC. | $84.07 | 2019-2022 | |
| Astellas Pharma US INC | $67.27 | 2019 | |
| Duchesnay USA Incorporated | $60.46 | 2019 | |
| Revance Therapeutics, INC. | $55.56 | 2024 | Daxxify |
| Bayer Healthcare Pharmaceuticals INC. | $55.13 | 2019-2023 | |
| Evofem Biosciences, INC. | $49.20 | 2021-2023 | Phexxi |
| Daiichi Sankyo INC. | $48.37 | 2019 | |
| Boston Scientific Corporation | $48.23 | 2019-2023 | Obtryx System - Curved |
| Exeltis, USA INC. | $47.34 | 2020-2023 | Slynd |
| Hologic Sales and Service, LLC | $30.29 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $29.35 | 2022 | |
| Organon LLC | $29.25 | 2022 | |
| Avion Pharmaceuticals | $25.43 | 2019-2022 | |
| Millicent US INC | $21.47 | 2020 | |
| Shield Therapeutics INC | $19.38 | 2022 | |
| Alydia Health | $17.30 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.73 | 2019 | |
| Vertical Pharmaceuticals, LLC | $15.30 | 2019 | |
| Ascend Therapeutics US, LLC | $13.92 | 2024 | |
| Mylan Pharmaceuticals INC. | $13.07 | 2019 | |
| Merck Sharp & Dohme LLC | $11.93 | 2019 | |
| Channel Medsystems, INC. | $9.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.